← Leaderboards
William M Grady
Vanderbilt University
$22,313,396
Attributed
$30,605,314
Total exposure
26
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,304,846 · 31
By mechanism
U54$19,213,724 · 8
R01$10,076,105 · 6
U01$9,342,004 · 2
U2C$6,145,759 · 5
P01$3,362,099 · 2
P20$3,135,828 · 3
Top collaborators
- Sanford D Markowitz18 shared
- Richard Brott Halberg15 shared
- Neelendu Dey11 shared
- Amitabh Chak6 shared
- Kishore Guda6 shared
- Perry Pickhardt6 shared
- Nicholas J Shaheen6 shared
- Cecilia C Yeung4 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Harold L Moses$33,288,478
- Christine H Chung$4,324,976
- Ty William Abel$838,243
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsColorectal CancerColonMolecularCessation Of LifeEpigenetic ProcessBaseResearch PersonnelBiological MarkersAdenomaEarly DiagnosisCollaborationsTumorInnovationEpithelial CellsBehaviorAffectProgramsCohortCellsEsophageal AdenocarcinomaLesionTissuesMutation
Grant awards (121)
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,579,708
U54 · FY2025 · CA · contact PI
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$1,029,753
U2C · FY2025 · CA · contact PI
Computational 3D pathology for Barrett's esophagus risk stratification$719,169
R01 · FY2025 · DK
A 4D-tunable hydrogel for the study of the impact of the tumor microenvironment on the development of colorectal cancer$537,714
R01 · FY2025 · CA
The role of the senescent microenvironment on cancer initiating cells in the colon.$464,341
U01 · FY2025 · AG · contact PI
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$428,074
U2C · FY2025 · CA · contact PI
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment$315,942
U54 · FY2025 · CA · contact PI
Administrative Core$315,941
U54 · FY2025 · CA · contact PI
Biomarker Development Laboratory$315,450
U2C · FY2025 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$255,000
U54 · FY2025 · CA · contact PI
Developmental Research Project$120,935
P50 · FY2025 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$100,184
U54 · FY2025 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,577,081
U54 · FY2024 · CA · contact PI
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$864,543
U2C · FY2024 · CA · contact PI
Computational 3D pathology for Barrett's esophagus risk stratification$752,672
R01 · FY2024 · DK
Administrative Core$565,226
U54 · FY2024 · CA · contact PI
A 4D-tunable hydrogel for the study of the impact of the tumor microenvironment on the development of colorectal cancer$512,478
R01 · FY2024 · CA
The role of the senescent microenvironment on cancer initiating cells in the colon.$481,298
U01 · FY2024 · AG · contact PI
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment$467,151
U54 · FY2024 · CA · contact PI
On-Demand Modulation of Extracellular Matrix Mechanics for Studying RhoA Activation in Primary and Metastatic Colorectal Cancer$428,361
R21 · FY2024 · CA
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$361,990
U2C · FY2024 · CA · contact PI
Biomarker Development Laboratory$268,409
U2C · FY2024 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$255,000
U54 · FY2024 · CA · contact PI
Administrative Core$178,226
U54 · FY2024 · CA · contact PI
Spatially Informed Malignancy Signatures for Colon Adenomas$178,226
U54 · FY2024 · CA · contact PI
Identifying Gut Microbial Inducers of Biological Aging in the Colon$176,000
U54 · FY2024 · CA · contact PI
Developmental Research Project$116,097
P50 · FY2024 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$100,184
U54 · FY2024 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,607,986
U54 · FY2023 · CA · contact PI
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$1,009,158
U2C · FY2023 · CA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$828,416
P20 · FY2023 · CA
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment$503,414
U54 · FY2023 · CA · contact PI
The role of the senescent microenvironment on cancer initiating cells in the colon.$489,084
U01 · FY2023 · AG · contact PI
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$382,885
U2C · FY2023 · CA · contact PI
Administrative Core$335,868
U54 · FY2023 · CA · contact PI
Biomarker Development Laboratory$290,377
U2C · FY2023 · CA · contact PI
The intestinal microbiome contribution to colon cancer and senescence$183,278
U01 · FY2023 · AG · contact PI
High-resolution mutational landscape of the primed colon in early onset colorectal cancer$174,911
U54 · FY2023 · CA · contact PI
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment$174,911
U54 · FY2023 · CA · contact PI
Novel biomarker strategies for HCC early detection in AI/AN patients$136,420
P20 · FY2023 · CA · contact PI
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome$1,692,618
U54 · FY2022 · CA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$850,177
P20 · FY2022 · CA
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$739,072
U2C · FY2022 · CA · contact PI
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment$679,511
U54 · FY2022 · CA · contact PI
The role of the senescent microenvironment on cancer initiating cells in the colon.$496,221
U01 · FY2022 · AG · contact PI
Biomarker Development Laboratory$347,889
U2C · FY2022 · CA · contact PI
University of Washington GI Training Grant$296,269
T32 · FY2022 · DK · contact PI
Novel biomarker strategies for HCC early detection in AI/AN patients$155,192
P20 · FY2022 · CA · contact PI
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus$108,159
U2C · FY2022 · CA · contact PI
Administrative Core$83,394
U54 · FY2022 · CA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$1,011,489
P20 · FY2021 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$491,493
R01 · FY2021 · CA · contact PI
The role of the senescent microenvironment on cancer initiating cells in the colon.$451,960
U01 · FY2021 · AG · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$407,598
U01 · FY2021 · CA
Novel biomarker strategies for HCC early detection in AI/AN patients$154,134
P20 · FY2021 · CA · contact PI
The role of the senescent microenvironment on cancer initiating cells in the colon.$69,415
U01 · FY2021 · AG · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$53,196
R01 · FY2021 · CA · contact PI
University of Washington GI Training Grant$24,215
T32 · FY2021 · DK · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$757,530
U01 · FY2020 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$544,256
R01 · FY2020 · CA · contact PI
University of Washington GI Training Grant$327,976
T32 · FY2020 · DK · contact PI
Barrett's Esophagus: Predictors of Progression$1,866,717
P01 · FY2019 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$788,470
U01 · FY2019 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$678,173
R01 · FY2019 · CA · contact PI
Research Program: Gastrointestinal Cancer$86,924
P30 · FY2019 · CA · contact PI
Research Program: Gastrointestinal Cancer$9,134
P30 · FY2019 · CA · contact PI
Research Program: Gastrointestinal Cancer$7,406
P30 · FY2019 · CA · contact PI
Research Program: Gastrointestinal Cancer$3,701
P30 · FY2019 · CA · contact PI
Research Program: Gastrointestinal Cancer$2,889
P30 · FY2019 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$706,863
U01 · FY2018 · CA
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$698,964
R01 · FY2018 · CA · contact PI
(PQC1) Accelerated biological aging and colon polyp to cancer progression$401,448
R01 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$86,922
P30 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$9,134
P30 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$8,332
P30 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$7,406
P30 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$2,889
P30 · FY2018 · CA · contact PI
Research Program: Gastrointestinal Cancer$1,234
P30 · FY2018 · CA · contact PI
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.$739,041
R01 · FY2017 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$596,898
U01 · FY2017 · CA
(PQC1) Accelerated biological aging and colon polyp to cancer progression$401,482
R01 · FY2017 · CA · contact PI
Research Program: Gastrointestinal Cancer$118,761
P30 · FY2017 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$617,094
U01 · FY2016 · CA
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$462,954
U54 · FY2016 · CA
(PQC1) Accelerated biological aging and colon polyp to cancer progression$401,515
R01 · FY2016 · CA · contact PI
Research Program: Gastrointestinal Cancer$87,231
P30 · FY2016 · CA · contact PI
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$1,446,550
U54 · FY2015 · CA
(PQC1) Accelerated biological aging and colon polyp to cancer progression$420,546
R01 · FY2015 · CA · contact PI
The Biology and Translation of Epigenetic Alterations in Barrett's Esophagus$220,882
U54 · FY2015 · CA · contact PI
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$183,131
U01 · FY2015 · CA · contact PI
Research Program: Gastrointestinal Cancer$89,613
P30 · FY2015 · CA · contact PI
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$1,424,703
U54 · FY2014 · CA
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$520,108
U01 · FY2014 · CA · contact PI
The Biology and Translation of Epigenetic Alterations in Barrett's Esophagus$280,041
U54 · FY2014 · CA · contact PI
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$1,268,396
U54 · FY2013 · CA
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$516,256
U01 · FY2013 · CA · contact PI
Human Tumor Analyses$280,047
P01 · FY2013 · CA · contact PI
The Biology and Translation of Epigenetic Alterations in Barrett's Esophagus$252,605
U54 · FY2013 · CA · contact PI
Core 2$101,894
U54 · FY2013 · CA · contact PI
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$1,174,448
U54 · FY2012 · CA
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$566,328
U01 · FY2012 · CA · contact PI
Human Tumor Analyses$298,844
P01 · FY2012 · CA · contact PI
The Biology and Translation of Epigenetic Alterations in Barrett's Esophagus$238,511
U54 · FY2012 · CA · contact PI
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA$1,026,258
U54 · FY2011 · CA
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$584,114
U01 · FY2011 · CA · contact PI
TGF-beta signaling and colon cancer$312,778
R01 · FY2011 · CA · contact PI
Human Tumor Analyses$299,789
P01 · FY2011 · CA · contact PI
Identify and validate novel epigenetic molecular markers for colorectal neoplasm$462,017
U01 · FY2010 · CA · contact PI
TGF-beta signaling and colon cancer$322,452
R01 · FY2010 · CA · contact PI
Human Tumor Analyses$311,559
P01 · FY2010 · CA · contact PI
TGF-beta signaling and colon cancer$324,058
R01 · FY2009 · CA · contact PI
Human Tumor Analyses$305,143
P01 · FY2009 · CA · contact PI
TGF-beta signaling and colon cancer$339,257
R01 · FY2008 · CA · contact PI
TGF-beta signaling and colon cancer$340,523
R01 · FY2007 · CA · contact PI
Effects of Loss of TGF-Beta Rll in the Liver$261,849
R01 · FY2006 · DK · contact PI
Effects of Loss of TGF-Beta Rll in the Liver$268,152
R01 · FY2005 · DK
Effects of Loss of TGF-Beta Rll in the Liver$268,152
R01 · FY2004 · DK
Effects of Loss of TGF-Beta Rll in the Liver$286,737
R01 · FY2003 · DK
TGF BETA RECEPTOR MUTATIONS AND HUMAN CANCER$17,966
K08 · FY2002 · CA
TGF BETA RECEPTOR MUTATIONS AND HUMAN CANCER$87,966
K08 · FY2001 · CA
TGF BETA RECEPTOR MUTATIONS AND HUMAN CANCER$87,966
K08 · FY2000 · CA